TRANSCRIPTIONAL REGULATION OF THE SACCHAROMYCES CEREVISIAE GENE ENCODING THE SMALL SUBUNIT OF RIBONUCLEOTIDE REDUCTASE NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


TRANSCRIPTIONAL REGULATION OF THE SACCHAROMYCES CEREVISIAE GENE ENCODING THE SMALL SUBUNIT OF RIBONUCLEOTIDE REDUCTASE

Diss Abstr Int [B]; 52(8):4033 1992. Unique Identifier : AIDSLINE ICDB/92682239
Hurd HK; Cornell Univ.


Abstract: The Saccharomyces cerevisiae gene that encodes the small subunit of ribonucleotide reductase, the enzyme that catalyzes the reduction of ribonucleoside diphosphates to deoxyribonucleoside diphosphates, was cloned and sequenced. The gene (RNR2) was further characterized by determining its copy number and by S1 mapping its transcriptional start site. The RNR2 protein was shown to be induced by the DNA-damaging agent methyl methanesulfonate. This induction was found to occur at the level of transcription and was shown to be independent of protein synthesis. An RNR2/LACZ fusion was constructed and used to identify other DNA-damaging agents that induced the RNR2 gene. The regulatory elements that control RNR2 induction were identified by a deletion analysis of the upstream region of RNR2. These elements, which consisted of two activation sites and a repression sequence, were contained on a fragment of approx 200 bp that was found to confer MMS inducibility on the heterologous CYC1 gene. A known transcriptional activator, the RAP1 protein was shown to bind to the downstream activation site; but RAP1 overproduction or depletion did not significantly affect RNR2 expression. These observations along with the result that RAP1 was found to be constitutively bound in vivo suggested that the RAP1 protein contributes to RNR2 expression, but it probably does not respond directly to an inducing signal. When the RNR2 repression sequence was inserted between the CYC1 activation sequences and TATA elements, it decreased the expression of the CYC1 gene. In addition, this repression was found to depend on SSN6, a protein required for the repression of a variety of other yeast genes. The RNR2 gene was also found to be induced by cell division cycle mutations that deplete cells of precursors used for DNA synthesis, which suggested that DNA damage and/or the inhibition of DNA replication could induce RNR2. In addition, methyl methanesulfonate induction was found to be reduced in a rad9 mutant, which is defective in cell cycle arrest, an event that normally accompanies DNA damage. This result further confirmed the view that the regulation of RNR2 expression is associated with processes of DNA repair. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD92-04061).
Keywords: Cell Division DNA/BIOSYNTHESIS DNA Damage DNA Repair DNA Replication *Gene Expression Regulation, Fungal Gene Products, vpr/METABOLISM Genes, vpr/GENETICS Genes, Fungal/*GENETICS Lac Operon/PHYSIOLOGY Mutation Ribonucleotide Reductases/*GENETICS Saccharomyces cerevisiae/*GENETICS TATA Box THESIS

KWDcelldivisiondna/biosynthesisdnadamagednarepairdnareplicationKWDgeneexpressionregulation,fungalgeneproducts,vpr/metabolismgenes,vpr/geneticsgenes,fungal/KWDgeneticslacoperon/physiologymutationribonucleotidereductases/KWDgeneticssaccharomycescerevisiae/KWDgeneticstataboxthesis
921130
M92B0885


Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .